Acute Crit Care.  2023 May;38(2):238-241. 10.4266/acc.2023.00437.

Septic shock due to invasive pulmonary aspergillosis without conventional risk factors

• Shin KE
• Park S
• Baek AR

• KMID: 2543645
• DOI: http://doi.org/10.4266/acc.2023.00437

Figure

• 

  Figure 1. (A) The initial chest radiograph shows increased opacities, mainly in the right lower lung field. (B) The last chest radiograph on the 74th day of admission reveals decreased opacities compared to (A).

• 

  Figure 2. (A) The coronal view of initial chest computed tomography (CT) shows bilateral multifocal nodules with surrounding ground-glass opacities (GGOs), the “Halo sign” (black arrows), and centrilobular emphysema (white arrowheads) in both lungs. (B) Axial images of the same CT scan reveal multiple nodules with surrounding GGO (black arrows in the above row) in both upper lobes and extensive consolidation with GGO (black arrows in the bottom row) in both lower lobes. (C) The follow-up axial CT images show aggravated nodular consolidations in the upper and lower lobes on the 13th day of admission. (D) The second follow-up axial chest CT images show partial improvement of nodular consolidations in the whole lung fields on the 45th day of admission.

• 

  Figure 3. Serum invasive fungal markers of galactomannan antigen (GM) and beta-D-glucan (BDG) levels were initially high but decreased upon treatment, with a persistent and intractable disease course.

Reference

1. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021; 49:e1063–143.

2. Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T, et al. How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care. 2014; 18:458.

3. Prohaska S, Henn P, Wenz S, Frauenfeld L, Rosenberger P, Haeberle HA. A case report of fatal disseminated fungal sepsis in a patient with ARDS and extracorporeal membrane oxygenation. BMC Anesthesiol. 2020; 20:107.

4. Bassetti M, Azoulay E, Kullberg BJ, Ruhnke M, Shoham S, Vazquez J, et al. EORTC/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis. 2021; 72(Suppl 2):S121–7.

5. Acosta J, Catalan M, del Palacio-Pérez-Medel A, Montejo JC, De-La-Cruz-Bértolo J, Moragues MD, et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. Eur J Clin Microbiol Infect Dis. 2012; 31:721–31.